Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
1 11月 2017
The view from Brussels – Brexit negotiations – Developments in October
31 10月 2017
The High Court considers the doctrine of equivalents in the context of patent infringement and novelty
19 9月 2017
EU unveils proposals for toughened security screening of foreign investments
5 9月 2017
ACCC v Medibank Private Limited: Court finds no misrepresentation in regards to out-of-pocket medical expenses
18 8月 2017
Frictionless trade? UK-EU customs relations post-Brexit
28 6月 2017
Pulse restored to scheme after side deal and voting commitment
16 6月 2017
Patent and Pharma update - June 2017
8 6月 2017
QATAR PROJECTS - WHAT TO DO NOW
16 5月 2017
How to reform Australia’s pharmacy sector
10 5月 2017
Pharmacy review must decide if pharmacists are healthcare professionals or retailers
8 5月 2017
Inside Construction and Infrastructure
3 5月 2017
More flexibility to threaten IP proceedings under new Unjustified Threats legislation
